Transient Global Ventricular Hypertrophy in a Patient With Multisystem Inflammatory Syndrome in Children (MIS-C) Correlated With High-Dose Glucocorticoid Treatment: A Case Report.

Autor:	West ZE; Department of Pediatrics, Emory University School of Medicine, Atlanta, USA.; Division of Pediatric Cardiology, Children's Healthcare of Atlanta, Atlanta, USA., Dove M; Department of Pediatrics, Emory University School of Medicine, Atlanta, USA.; Division of Pediatric Cardiology, Children's Healthcare of Atlanta, Atlanta, USA., Kochilas LK; Department of Pediatrics, Emory University School of Medicine, Atlanta, USA.; Division of Pediatric Cardiology, Children's Healthcare of Atlanta, Atlanta, USA., Oster ME; Department of Pediatrics, Emory University School of Medicine, Atlanta, USA.; Division of Pediatric Cardiology, Children's Healthcare of Atlanta, Atlanta, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2022 Dec 02; Vol. 14 (12), pp. e32139. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).
DOI:	10.7759/cureus.32139
Abstrakt:	Multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection has been shown to lead to depressed cardiac function. Standard treatment includes high-dose glucocorticoids (GC). We present the unusual case of a teenager who developed transient echocardiographic global ventricular hypertrophy following GC administration during his treatment for MIS-C, with the resolution of the hypertrophy after cessation of GC. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, West et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu